is glp 1 safe for kidneys GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity Renoprotective mechanisms of glucagon-like peptide-1

[93] These results concluded that Dapagliflozin does not result in a statistically significant lower chance of MACE compared to placebo and is associated with only a 17% cardiovascular risk reduction

The medications themselves are FDA-approved for specific indications (diabetes and/or obesity), but microdosing is an off-label dosing strategy used at physician discretion based on individual response and goals

His pediatrician didn't like the idea of interventions other than diet and exercise to help children lose weight, so Ambiyo didn't even want to bring up GLP-1s

The cost is important: over half of GLP-1 users say these medications are difficult to afford, even with coupons and insurance

After all, its difficult to feel emotionally well when you feel physically unwell every day

Both are GLP-1 receptor agonists, but they work through slightly different mechanisms